Other Species / Isoforms
  TAB2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T654-p
DQRSIIktPkTQDTE
Upstream
0 3
Treatment
  • ischemia
TAB2 (human) DQRSIIktPkTQDTE T654-p
TAB2 iso2 (human) gap -
TAB2 (mouse) DQRSTIKAPKTQDAE A654
TAB2 (rat) DQRSTIKAPKTQDTE A654
T171-p
TSSLSQQtPrFNPIM
0 4
TAB2 (human) TSSLSQQtPrFNPIM T171-p
TAB2 iso2 (human) TSSLSQQTPRFNPIM T171
TAB2 (mouse) TSNLSQQTPrFNPIM T171
TAB2 (rat) TSNLSQQTPRFNPIM T171
R173-m1
SLSQQtPrFNPIMVT
0 10
TAB2 (human) SLSQQtPrFNPIMVT R173-m1
TAB2 iso2 (human) SLSQQTPRFNPIMVT R173
TAB2 (mouse) NLSQQTPRFNPIMVT R173
TAB2 (rat) NLSQQTPRFNPIMVT R173
R173-m2
SLSQQtPrFNPIMVT
0 10
TAB2 (human) SLSQQtPrFNPIMVT R173-m2
TAB2 iso2 (human) SLSQQTPRFNPIMVT R173
TAB2 (mouse) NLSQQTPrFNPIMVT R173-m2
TAB2 (rat) NLSQQTPRFNPIMVT R173
K329-sm
RKNQIEIkLEPPQRN
Upstream
Downstream
2 0
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • signaling pathway regulation
  • transcription, inhibited
Treatment
  • LPS
TAB2 (human) RKNQIEIkLEPPQRN K329-sm
TAB2 iso2 (human) RKNQIEIKLEPPQRN K329
TAB2 (mouse) RKNQIEIkLEPPQRN K329-sm
TAB2 (rat) RKNQIEIKLEPPQRN K329
S350-p
SSGPRTSsTSSSVNS
Upstream
0 5
Treatment
  • ischemia
TAB2 (human) SSGPRTSsTSSSVNS S350-p
TAB2 iso2 (human) SSGPRTSSTSSSVNS S350
TAB2 (mouse) SSGPRTAsTSSLVNS S350-p
TAB2 (rat) SSGPRTASTSSLVNS S350
S372-p
PTVYIAAsPPNTDEL
Upstream
1 9
TAB2 (human)
S372-p
TAB2 (mouse)
S372-p
Regulatory protein:
  • JNK1 (human)
  • JNK2 (human)
Treatment
  • BIRB-0796
  • IL-1b
  • PD184352
  • SB203580
TAB2 (human) PTVYIAAsPPNTDEL S372-p
TAB2 iso2 (human) PTVYIAASPPNTDEL S372
TAB2 (mouse) PTVYIAAsPPNTDEM S372-p
TAB2 (rat) PTVYIAAsPPSTDEM S372-p
S413-p
TLFISTNsGASAAsR
0 1
TAB2 (human) TLFISTNsGASAAsR S413-p
TAB2 iso2 (human) TLFISTNSGASAASR S413
TAB2 (mouse) TLFISTNSGPSAASR S413
TAB2 (rat) TLFISTNSGASAASR S413
S419-p
NsGASAAsRNMsGQV
Downstream
2 0
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
TAB2 (human) NsGASAAsRNMsGQV S419-p
TAB2 iso2 (human) NSGASAASRNMSGQV S419
TAB2 (mouse) NSGPSAASRNMSGQV S419
TAB2 (rat) NSGASAASRNMSGQV S419
S423-p
SAAsRNMsGQVSMGP
Downstream
2 0
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
TAB2 (human) SAAsRNMsGQVSMGP S423-p
TAB2 iso2 (human) SAASRNMSGQVSMGP S423
TAB2 (mouse) SAASRNMSGQVSMGP S423
TAB2 (rat) SAASRNMSGQVSMGP S423
S440-p
IHHHPPKsrAIGNNs
0 1
TAB2 (human) IHHHPPKsrAIGNNs S440-p
TAB2 iso2 (human) IHHHPPKSRAIGNNS S440
TAB2 (mouse) IHHHPPKSRVLGGNS S440
TAB2 (rat) IHHHPPKSRVLGGNS S440
R441-m1
HHHPPKsrAIGNNsA
0 1
TAB2 (human) HHHPPKsrAIGNNsA R441-m1
TAB2 iso2 (human) HHHPPKSRAIGNNSA R441
TAB2 (mouse) HHHPPKSRVLGGNSA R441
TAB2 (rat) HHHPPKSRVLGGNSA R441
S447-p
srAIGNNsAtsPRVV
0 1
TAB2 (human) srAIGNNsAtsPRVV S447-p
TAB2 iso2 (human) SRAIGNNSATSPRVV S447
TAB2 (mouse) SRVLGGNSAtsPRVV S447
TAB2 (rat) SRVLGGNSAASPRVV S447
T449-p
AIGNNsAtsPRVVVt
0 2
TAB2 (human) AIGNNsAtsPRVVVt T449-p
TAB2 iso2 (human) AIGNNSATSPRVVVT T449
TAB2 (mouse) VLGGNSAtsPRVVVt T449-p
TAB2 (rat) VLGGNSAASPRVVVT A449
S450-p
IGNNsAtsPRVVVtQ
Upstream
1 20
Treatment
  • EGF
  • nocodazole
  • SB202190
TAB2 (human) IGNNsAtsPRVVVtQ S450-p
TAB2 iso2 (human) IGNNSATSPRVVVTQ S450
TAB2 (mouse) LGGNSAtsPRVVVtQ S450-p
TAB2 (rat) LGGNSAASPRVVVTQ S450
T456-p
tsPRVVVtQPNTKYT
0 1
TAB2 (human) tsPRVVVtQPNTKYT T456-p
TAB2 iso2 (human) TSPRVVVTQPNTKYT T456
TAB2 (mouse) tsPRVVVTQPNTKYT T456
TAB2 (rat) ASPRVVVTQPNTKYT T456
T456
tsPRVVVTQPNTKYT
0 1
TAB2 (human) tsPRVVVTQPNTKYT T456
TAB2 iso2 (human) TSPRVVVTQPNTKYT T456
TAB2 (mouse) tsPRVVVtQPNTKYT T456-gl
TAB2 (rat) ASPRVVVTQPNTKYT T456
S477-p
PNKPPAVsPGVVsPt
Upstream
0 3
Regulatory protein:
  • TAK1 (human)
Treatment
  • bacterial infection
TAB2 (human) PNKPPAVsPGVVsPt S477-p
TAB2 iso2 (human) PNKPPAVSPGVVSPT S477
TAB2 (mouse) PNKPPAVsPGVVSPT S477-p
TAB2 (rat) PNKPPAVSPGVVSPT S477
S482-p
AVsPGVVsPtFELtN
Upstream
0 2
Regulatory protein:
  • TAK1 (human)
Treatment
  • bacterial infection
TAB2 (human) AVsPGVVsPtFELtN S482-p
TAB2 iso2 (human) AVSPGVVSPTFELTN S482
TAB2 (mouse) AVsPGVVSPTFELTN S482
TAB2 (rat) AVSPGVVSPTFELTN S482
T484-p
sPGVVsPtFELtNLL
Upstream
0 2
Regulatory protein:
  • TAK1 (human)
Treatment
  • bacterial infection
TAB2 (human) sPGVVsPtFELtNLL T484-p
TAB2 iso2 (human) SPGVVSPTFELTNLL T484
TAB2 (mouse) sPGVVSPTFELTNLL T484
TAB2 (rat) SPGVVSPTFELTNLL T484
T488-p
VsPtFELtNLLNHPD
Upstream
0 1
Regulatory protein:
  • TAK1 (human)
Treatment
  • bacterial infection
TAB2 (human) VsPtFELtNLLNHPD T488-p
TAB2 iso2 (human) VSPTFELTNLLNHPD T488
TAB2 (mouse) VSPTFELTNLLNHPD T488
TAB2 (rat) VSPTFELTNLLNHPD T488
K522-ub
DRISETRkLsMGsDD
0 1
TAB2 (human) DRISETRkLsMGsDD K522-ub
TAB2 iso2 (human) DRISETRKLSMGSDD K522
TAB2 (mouse) DRISEARKLsMGsDD K522
TAB2 (rat) DRVSEARKLSMGSDD K522
S524-p
ISETRkLsMGsDDAA
Upstream
1 20
Treatment
  • BIRB-0796
  • IL-1b
  • nocodazole
  • PD184352
  • SB203580
  • SII_angiotensin_2
TAB2 (human) ISETRkLsMGsDDAA S524-p
TAB2 iso2 (human) ISETRKLSMGSDDAA S524
TAB2 (mouse) ISEARKLsMGsDDAA S524-p
TAB2 (rat) VSEARKLSMGSDDAA S524
S527-p
TRkLsMGsDDAAyTQ
Upstream
0 6
Treatment
  • BI2536
TAB2 (human) TRkLsMGsDDAAyTQ S527-p
TAB2 iso2 (human) TRKLSMGSDDAAYTQ S527
TAB2 (mouse) ARKLsMGsDDAAYTQ S527-p
TAB2 (rat) ARKLSMGSDDAAYTQ S527
Y532-p
MGsDDAAyTQALLVH
0 1
TAB2 (human) MGsDDAAyTQALLVH Y532-p
TAB2 iso2 (human) MGSDDAAYTQDI___ Y532
TAB2 (mouse) MGsDDAAYTQALLVH Y532
TAB2 (rat) MGSDDAAYTQALLVH Y532
K562-sm
KKKLDKLkSEVNEME
Upstream
Downstream
1 0
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • signaling pathway regulation
  • transcription, inhibited
Treatment
  • LPS
TAB2 (human) KKKLDKLkSEVNEME K562-sm
TAB2 iso2 (human) gap -
TAB2 (mouse) KKKLDKLksEVNEME K562-sm
TAB2 (rat) KKKLDKLKSEVNEME K562
S563
KKLDKLkSEVNEMEN
0 1
TAB2 (human) KKLDKLkSEVNEMEN S563
TAB2 iso2 (human) gap -
TAB2 (mouse) KKLDKLksEVNEMEN S563-p
TAB2 (rat) KKLDKLKSEVNEMEN S563
T573
NEMENNLTRRRLKRs
0 1
TAB2 (human) NEMENNLTRRRLKRs T573
TAB2 iso2 (human) gap -
TAB2 (mouse) NEMENNLtRRRLKRS T573-p
TAB2 (rat) NEMENSLTRRRLKRS T573
S580-p
TRRRLKRsNsISQIP
0 1
TAB2 (human) TRRRLKRsNsISQIP S580-p
TAB2 iso2 (human) gap -
TAB2 (mouse) tRRRLKRSNsISQIP S580
TAB2 (rat) TRRRLKRSNSMSQIP S580
S582-p
RRLKRsNsISQIPsL
Upstream
1 8
Treatment
  • IL-1b
  • ischemia
TAB2 (human) RRLKRsNsISQIPsL S582-p
TAB2 iso2 (human) gap -
TAB2 (mouse) RRLKRSNsISQIPSL S582-p
TAB2 (rat) RRLKRSNSMSQIPSL S582
S588-p
NsISQIPsLEEMQQL
0 1
TAB2 (human) NsISQIPsLEEMQQL S588-p
TAB2 iso2 (human) gap -
TAB2 (mouse) NsISQIPSLEEMQQL S588
TAB2 (rat) NSMSQIPSLEEMQQL S588
K611-ub
IDIDCLTkEIDLFQA
0 9
TAB2 (human) IDIDCLTkEIDLFQA K611-ub
TAB2 iso2 (human) gap -
TAB2 (mouse) IDIDCLTkEIDLFQA K611-ub
TAB2 (rat) IDIDCLTKEIDLFQA K611
Y632-p
PSAIHNFyDNIGFVG
0 3
TAB2 (human) PSAIHNFyDNIGFVG Y632-p
TAB2 iso2 (human) gap -
TAB2 (mouse) PSAIHNFYDNIGFVG Y632
TAB2 (rat) PSAIHNFYDNIGFVG Y632
K653-ub
KDQRSIIktPkTQDT
0 4
TAB2 (human) KDQRSIIktPkTQDT K653-ub
TAB2 iso2 (human) gap -
TAB2 (mouse) KDQRSTIKAPKTQDA K653
TAB2 (rat) KDQRSTIKAPKTQDT K653
K656-ub
RSIIktPkTQDTEDD
0 2
TAB2 (human) RSIIktPkTQDTEDD K656-ub
TAB2 iso2 (human) gap -
TAB2 (mouse) RSTIKAPKTQDAEDE K656
TAB2 (rat) RSTIKAPKTQDTEDE K656